United Imaging Intelligence

联影智能 provides AI-based medical applications, including medical imaging and artificial intelligence diagnostic systems.

联影智能 offers a comprehensive AI solution for cardiovascular diseases, covering coronary artery lesions, pericardial vascular diseases, and myocardial function assessment. Its cardiac AI technology enables rapid 3D heart imaging reconstruction to help physicians manage complex cases efficiently.

联影智能’s cerebrovascular disease solution uses AI-powered head and neck vascular technology to provide a full-process, cross-time, and cross-space consultation workflow, enabling AI imaging to directly support clinical decisions with multi-dimensional precision analysis.

联影智能 is a leading AI healthcare company in China, offering patient-centered intelligent diagnostic solutions that cover imaging screening, diagnosis, treatment, and follow-up, as well as a full lifecycle health management system. Its AI medical imaging technology aids in early tumor detection and precision treatment.

The page describes traffic congestion near Tianjin Hospital, a major orthopedic center in Tianjin’s Hexi District.

The World Health Organization’s International Agency for Research on Cancer (IARC) reports China had 4.57 million new cancer cases in 2020. Brain metastasis occurs in 20–65% of lung cancer patients, per the 2021 *Lung Cancer Brain Metastasis Treatment Guidelines in China*.

联影智能 offers AI-powered solutions for clinical, research, and equipment applications across multiple disease types and scenarios, including hospital management, medical innovation ecosystems, workflow optimization, precision diagnostics, and personal health management.

联影智能 is an AI company under the United Imaging Group, leveraging the group’s high-performance software and hardware technology platform to deliver integrated AI solutions for medical applications, including clinical, research, and equipment innovation.